Skip to content

Investigation of incidence of measles, mumps and rubella in patients with inflammatory bowel disease

Investigation of incidence of measles, mumps and rubella in patients with inflammatory bowel disease - Serological test and vaccinations for measles, mumps and rubella in patients with inflammatory bowel disease

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000005443
Enrollment
100
Registered
2011-04-14
Start date
2010-11-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ulcerative colitis, Crohn&#39

Interventions

None listed

Sponsors

Gastroenterology and Hepatology Tokyo Medicaland Dental University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients with diagnosed UC and CD Age is more than 16 Male and female patients can be entried to this study

Exclusion criteria

Exclusion criteria: Only UC and CD patients can be included.

Design outcomes

Primary

MeasureTime frame
Investigation of seronegative rates for measles, mumps, rubella and varicella zoster in IBD patients treated with 5-ASA, steroids, immunomodulators, and biologics.

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026